臨床試驗

CnF-DBS for Levodopa-Resistant FOG

NCT：NCT07781696 · NOT_YET_RECRUITING

NCT IDNCT07781696

狀態NOT_YET_RECRUITING

SponsorIahn Cajigas (OTHER)

First posted2026-08-24

Last updated2026-08-24

簡要摘要

The purpose of this trial is to study the safety, practicality, and effectiveness of deep brain stimulation (DBS) therapy in a brain region called the cuneiform nucleus (CnF) to treat disabling freezing of gait (FOG) in patients with Parkinson's disease (PD) when standard treatments are no longer effective. The study uses either the Medtronic's Percept™ PC or RC systems for DBS therapy. Please note that although the Medtronic systems are FDA-approved for other diseases, they have not been approved for the treatment of FOG in PD and their use for stimulation of the CnF target is experimental.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。